KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Liabilities (2016 - 2026)

West Pharmaceutical Services has reported Total Liabilities over the past 18 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly Total Liabilities rose 19.71% to $1.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Mar 2026, up 19.71% year-over-year, with the annual reading at $1.1 billion for FY2025, 13.83% up from the prior year.
  • Total Liabilities was $1.1 billion for Q1 2026 at West Pharmaceutical Services, up from $1.1 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $1.1 billion in Q1 2026 and troughed at $846.0 million in Q3 2022.
  • The 5-year median for Total Liabilities is $937.3 million (2022), against an average of $960.8 million.
  • Biggest five-year swings in Total Liabilities: decreased 10.03% in 2022 and later rose 19.71% in 2026.
  • Tracing WST's Total Liabilities over 5 years: stood at $931.9 million in 2022, then rose by 1.78% to $948.5 million in 2023, then grew by 1.33% to $961.1 million in 2024, then increased by 13.83% to $1.1 billion in 2025, then rose by 2.32% to $1.1 billion in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.